Skip to main content
Top
Published in: Rheumatology International 4/2011

01-04-2011 | Short Communication

Expression levels and association of gelatinases MMP-2 and MMP-9 and collagenases MMP-1 and MMP-13 with VEGF in synovial fluid of patients with arthritis

Authors: Kyoung Soo Kim, Hyun Mi Choi, Yeon-Ah Lee, In Ah Choi, Sang-Hoon Lee, Seung-Jae Hong, Hyung-In Yang, Myung Chul Yoo

Published in: Rheumatology International | Issue 4/2011

Login to get access

Abstract

This study was performed to provide evidence, albeit indirectly, as to which matrix metalloproteinases (MMPs), among the gelatinases MMP-2 and MMP-9 and the collagenases MMP-1 and MMP-13, play a more proactive role in the angiogenic process in arthritic joint. Joint fluid was collected from 33 patients with rhuematoid arthritis (RA) and osteoarthritis (OA), and protein (MMPs and vascular endothelial growth factor (VEGF)) levels were measured by ELISA, and the association of MMPs with VEGF was evaluated in joint fluid of patients with RA or OA. The levels of collagenases (total MMP-1 and total MMP-13) and gelatinases (total MMP-2 and total MMP-9) in RA joint fluid were significantly higher than those in OA fluid. Total MMP-9 levels were significantly associated with VEGF levels in RA fluids, but not in OA fluid, while total MMP-13 levels were strongly associated with VEGF levels in both RA and OA fluid. However, total MMP-2 and total MMP-1 levels were not associated with VEGF levels in either RA or OA joint fluid. Our results indirectly suggest that in RA and OA, MMP-9 and MMP-13 may play a more important role in angiogenesis than MMP-2 and MMP-1.
Literature
1.
go back to reference Murphy G, Knauper V, Atkinson S, Butler G, English W, Hutton M et al (2002) Matrix metalloproteinases in arthritic disease. Arthritis Res 4(Suppl 3):S39–S49PubMedCrossRef Murphy G, Knauper V, Atkinson S, Butler G, English W, Hutton M et al (2002) Matrix metalloproteinases in arthritic disease. Arthritis Res 4(Suppl 3):S39–S49PubMedCrossRef
2.
go back to reference Burrage PS, Mix KS, Brinckerhoff CE (2006) Matrix metalloproteinases: role in arthritis. Front Biosci 11:529–543PubMedCrossRef Burrage PS, Mix KS, Brinckerhoff CE (2006) Matrix metalloproteinases: role in arthritis. Front Biosci 11:529–543PubMedCrossRef
3.
go back to reference Weber AJ, De Bandt M (2000) Angiogenesis: general mechanisms and implications for rheumatoid arthritis. Joint Bone Spine 67(5):366–383PubMed Weber AJ, De Bandt M (2000) Angiogenesis: general mechanisms and implications for rheumatoid arthritis. Joint Bone Spine 67(5):366–383PubMed
4.
go back to reference Burbridge MF, Coge F, Galizzi JP, Boutin JA, West DC, Tucker GC (2002) The role of the matrix metalloproteinases during in vitro vessel formation. Angiogenesis 5(3):215–226PubMedCrossRef Burbridge MF, Coge F, Galizzi JP, Boutin JA, West DC, Tucker GC (2002) The role of the matrix metalloproteinases during in vitro vessel formation. Angiogenesis 5(3):215–226PubMedCrossRef
5.
go back to reference Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D et al (1998) MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93(3):411–422PubMedCrossRef Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D et al (1998) MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93(3):411–422PubMedCrossRef
6.
go back to reference Yu Q, Stamenkovic I (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 14(2):163–176PubMed Yu Q, Stamenkovic I (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 14(2):163–176PubMed
7.
go back to reference Zijlstra A, Aimes RT, Zhu D, Regazzoni K, Kupriyanova T, Seandel M et al (2004) Collagenolysis-dependent angiogenesis mediated by matrix metalloproteinase-13 (collagenase-3). J Biol Chem 279(26):27633–27645PubMedCrossRef Zijlstra A, Aimes RT, Zhu D, Regazzoni K, Kupriyanova T, Seandel M et al (2004) Collagenolysis-dependent angiogenesis mediated by matrix metalloproteinase-13 (collagenase-3). J Biol Chem 279(26):27633–27645PubMedCrossRef
8.
go back to reference Netzel-Arnett S, Mitola DJ, Yamada SS, Chrysovergis K, Holmbeck K, Birkedal-Hansen H et al (2002) Collagen dissolution by keratinocytes requires cell surface plasminogen activation and matrix metalloproteinase activity. J Biol Chem 277(47):45154–45161PubMedCrossRef Netzel-Arnett S, Mitola DJ, Yamada SS, Chrysovergis K, Holmbeck K, Birkedal-Hansen H et al (2002) Collagen dissolution by keratinocytes requires cell surface plasminogen activation and matrix metalloproteinase activity. J Biol Chem 277(47):45154–45161PubMedCrossRef
9.
go back to reference Kim KS, Park EK, Ju SM, Jung HS, Bang JS, Kim C et al (2007) Taurine chloramine differentially inhibits matrix metalloproteinase 1 and 13 synthesis in interleukin-1beta stimulated fibroblast-like synoviocytes. Arthritis Res Ther 9(4):R80PubMedCrossRef Kim KS, Park EK, Ju SM, Jung HS, Bang JS, Kim C et al (2007) Taurine chloramine differentially inhibits matrix metalloproteinase 1 and 13 synthesis in interleukin-1beta stimulated fibroblast-like synoviocytes. Arthritis Res Ther 9(4):R80PubMedCrossRef
10.
go back to reference Bouis D, Kusumanto Y, Meijer C, Mulder NH, Hospers GA (2006) A review on pro- and anti-angiogenic factors as targets of clinical intervention. Pharmacol Res 53(2):89–103PubMedCrossRef Bouis D, Kusumanto Y, Meijer C, Mulder NH, Hospers GA (2006) A review on pro- and anti-angiogenic factors as targets of clinical intervention. Pharmacol Res 53(2):89–103PubMedCrossRef
11.
go back to reference Wang H, Keiser JA (1998) Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1. Circ Res 83(8):832–840PubMed Wang H, Keiser JA (1998) Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1. Circ Res 83(8):832–840PubMed
12.
go back to reference Fraser A, Fearon U, Reece R, Emery P, Veale DJ (2001) Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis. Arthritis Rheum 44(9):2024–2028PubMedCrossRef Fraser A, Fearon U, Reece R, Emery P, Veale DJ (2001) Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis. Arthritis Rheum 44(9):2024–2028PubMedCrossRef
13.
go back to reference Goldbach-Mansky R, Lee JM, Hoxworth JM, Smith D II, Duray P, Schumacher RH Jr et al (2000) Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis. Arthritis Res 2(2):145–153PubMedCrossRef Goldbach-Mansky R, Lee JM, Hoxworth JM, Smith D II, Duray P, Schumacher RH Jr et al (2000) Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis. Arthritis Res 2(2):145–153PubMedCrossRef
14.
go back to reference Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K et al (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2(10):737–744PubMedCrossRef Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K et al (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2(10):737–744PubMedCrossRef
15.
go back to reference Heilpern AJ, Wertheim W, He J, Perides G, Bronson RT, Hu LT (2009) Matrix metalloproteinase 9 plays a key role in lyme arthritis but not in dissemination of Borrelia burgdorferi. Infect Immun 77(7):2643–2649PubMedCrossRef Heilpern AJ, Wertheim W, He J, Perides G, Bronson RT, Hu LT (2009) Matrix metalloproteinase 9 plays a key role in lyme arthritis but not in dissemination of Borrelia burgdorferi. Infect Immun 77(7):2643–2649PubMedCrossRef
16.
go back to reference Itoh T, Matsuda H, Tanioka M, Kuwabara K, Itohara S, Suzuki R (2002) The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis. J Immunol 169(5):2643–2647PubMed Itoh T, Matsuda H, Tanioka M, Kuwabara K, Itohara S, Suzuki R (2002) The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis. J Immunol 169(5):2643–2647PubMed
17.
go back to reference Sang QX (1998) Complex role of matrix metalloproteinases in angiogenesis. Cell Res 8(3):171–177PubMed Sang QX (1998) Complex role of matrix metalloproteinases in angiogenesis. Cell Res 8(3):171–177PubMed
18.
go back to reference Tchetverikov I, Ronday HK, Van El B, Kiers GH, Verzijl N, TeKoppele JM et al (2004) MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis. Ann Rheum Dis 63(7):881–883PubMedCrossRef Tchetverikov I, Ronday HK, Van El B, Kiers GH, Verzijl N, TeKoppele JM et al (2004) MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis. Ann Rheum Dis 63(7):881–883PubMedCrossRef
19.
go back to reference Yoshihara Y, Nakamura H, Obata K, Yamada H, Hayakawa T, Fujikawa K et al (2000) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis 59(6):455–461PubMedCrossRef Yoshihara Y, Nakamura H, Obata K, Yamada H, Hayakawa T, Fujikawa K et al (2000) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis 59(6):455–461PubMedCrossRef
Metadata
Title
Expression levels and association of gelatinases MMP-2 and MMP-9 and collagenases MMP-1 and MMP-13 with VEGF in synovial fluid of patients with arthritis
Authors
Kyoung Soo Kim
Hyun Mi Choi
Yeon-Ah Lee
In Ah Choi
Sang-Hoon Lee
Seung-Jae Hong
Hyung-In Yang
Myung Chul Yoo
Publication date
01-04-2011
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 4/2011
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-010-1592-1

Other articles of this Issue 4/2011

Rheumatology International 4/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.